Drugs / dihydroxyprogesterone caproate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01501890 Comparator | Jan 2012 → Dec 2013 | fetal growth restriction, habitual spontaneous abortion, placental abruption, preeclampsia | Soroka University Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dihydroxyprogesterone caproate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01501890 ↗ |
| Route | Intramuscular | “250mg once a week by intramuscular administration” NCT01501890 ↗ |